These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8424817

  • 21. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR, Kaufmann WK, Chaney SG.
    Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
    [Abstract] [Full Text] [Related]

  • 22. Intracellular glutathione and cytotoxicity of platinum complexes.
    Pendyala L, Creaven PJ, Perez R, Zdanowicz JR, Raghavan D.
    Cancer Chemother Pharmacol; 1995 Dec; 36(4):271-8. PubMed ID: 7628045
    [Abstract] [Full Text] [Related]

  • 23. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
    Hofs HP, Wagener TD, de Valk-Bakker V, van Rennes H, Doesburg WH, Ottenheijm HC, de Grip WJ.
    Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA.
    Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513
    [Abstract] [Full Text] [Related]

  • 25. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance.
    Ishikawa T, Ali-Osman F.
    J Biol Chem; 1993 Sep 25; 268(27):20116-25. PubMed ID: 8376370
    [Abstract] [Full Text] [Related]

  • 26. Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.
    Tashiro T, Sato Y.
    Jpn J Cancer Res; 1992 Feb 25; 83(2):219-25. PubMed ID: 1556003
    [Abstract] [Full Text] [Related]

  • 27. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG.
    Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108
    [Abstract] [Full Text] [Related]

  • 28. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 15; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 29. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA, Hosking LK, Hill BT.
    Cancer Res; 1991 Sep 01; 51(17):4557-64. PubMed ID: 1873800
    [Abstract] [Full Text] [Related]

  • 30. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF.
    Cancer Res; 1987 Jan 15; 47(2):414-8. PubMed ID: 3539322
    [Abstract] [Full Text] [Related]

  • 31. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
    Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV.
    Cancer Res; 1988 Apr 01; 48(7):1745-52. PubMed ID: 3162402
    [Abstract] [Full Text] [Related]

  • 32. Mechanisms of acquired resistance to the orally active platinum-based anticancer drug bis-acetato-ammine-dichloro-cyclohexylamine platinum (i.v.) (JM216) in two human ovarian carcinoma cell lines.
    Mellish KJ, Kelland LR.
    Cancer Res; 1994 Dec 01; 54(23):6194-200. PubMed ID: 7954466
    [Abstract] [Full Text] [Related]

  • 33. Glutathione-mediated activation of anticancer platinum(IV) complexes.
    Eastman A.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4177-8. PubMed ID: 3689445
    [No Abstract] [Full Text] [Related]

  • 34. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 35. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR.
    Cancer Res; 1993 Jun 01; 53(11):2581-6. PubMed ID: 8388318
    [Abstract] [Full Text] [Related]

  • 36. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.
    Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T.
    Biochem Pharmacol; 1996 Dec 24; 52(12):1855-65. PubMed ID: 8951344
    [Abstract] [Full Text] [Related]

  • 37. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
    Waud WR.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6549-55. PubMed ID: 3677093
    [Abstract] [Full Text] [Related]

  • 38. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR.
    Cancer Res; 1992 Jul 15; 52(14):3857-64. PubMed ID: 1617660
    [Abstract] [Full Text] [Related]

  • 39. Development of resistance to a trinuclear platinum complex in ovarian carcinoma cells.
    Perego P, Gatti L, Righetti SC, Beretta GL, Carenini N, Corna E, Dal Bo L, Tinelli S, Colangelo D, Leone R, Apostoli P, Lombardi L, Beggiolin G, Piazzoni L, Zunino F.
    Int J Cancer; 2003 Jul 10; 105(5):617-24. PubMed ID: 12740909
    [Abstract] [Full Text] [Related]

  • 40. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 10; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.